TGFK-09SD

TGFK-09SD
Clinical data
Other names	TGFK09SD
Routes of; administration	Oral
Drug class	Serotonin 5-HT1A receptor agonist
ATC code	None;

Other namesTGFK09SD

TGFK-09SD, or TGFK09SD, is a serotonin 5-HT_1A receptor agonist which is or was under development for the treatment of female sexual dysfunction but was never marketed.^[1]^[2] It is taken orally.^[1] The drug was developed by Fabre-Kramer Pharmaceuticals.^[1] As of January 2016, it is in phase 2 clinical trials.^[1] There have been no further updates on the development of the drug since then.^[1] The chemical structure of TGFK-09SD does not yet appear to have been disclosed.^[1]

v t e Sexual dysfunction medications
Dopamine agonists	Apomorphine Cabergoline Lisuride Pergolide Piribedil Pramipexole Quinagolide Ropinirole Rotigotine Terguride
Melanocortin agonists	Bremelanotide Melanotan II PL-6983
PDE5 inhibitors	Acetildenafil Aildenafil Avanafil Icariin Lodenafil Mirodenafil Nitrosoprodenafil Sildenafil Sulfoaildenafil Tadalafil Udenafil Vardenafil
Sex steroids	Androgens (e.g., testosterone, methyltestosterone, other anabolic steroids) Estrogens (e.g., estradiol, ethinylestradiol, conjugated equine estrogens (Premarin)) Progestogens (e.g., progesterone, progestins) Mixed (e.g., tibolone)
Others	Afrodor (acecarbromal, quebracho, vitamin E) Alkyl nitrites Alprostadil Amantadine Bupropion Buspirone Cyproheptadine Dapoxetine Flibanserin Mirtazapine Moxisylyte Oxytocin Papaverine Phentolamine Psychostimulants (e.g., amphetamines, cocaine, methylphenidate) Rauwolscine (Rauvolfia) Trazodone Yohimbine (Yohimbe)
See also: Drugs for erectile dysfunction and premature ejaculation

References

Clinical data
Other names	TGFK09SD
Routes of administration	Oral^[1]
Drug class	Serotonin 5-HT_1A receptor agonist
ATC code	None